HUNTINGTON NATIONAL BANK - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 6 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q3 2023$010.0%0.00%
Q2 2023$010.0%0.00%
Q1 2023$010.0%0.00%
Q4 2022$010.0%0.00%
Q3 2022$010.0%0.00%
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$010.0%0.00%
Q3 2021$010.0%0.00%
Q2 2021$010.0%0.00%
Q1 2021$010.0%0.00%
Q4 2020$010.0%0.00%
Q3 2020$010.0%0.00%
Q2 2020$010.0%0.00%
Q1 2020$010.0%0.00%
Q4 2019$010.0%0.00%
Q3 2019$010.0%0.00%
Q2 2019$010.0%0.00%
Q4 2018$010.0%0.00%
Q3 2018$01
-99.5%
0.00%
Q4 2016$02000.0%0.00%
Q3 2016$0
-100.0%
200
-99.3%
0.00%
Q2 2016$10,00027,200
+13500.0%
0.00%
Q1 2016$02000.0%0.00%
Q4 2015$02000.0%0.00%
Q3 2015$0
-100.0%
2000.0%0.00%
Q2 2015$1,0002000.0%0.00%
Q1 2015$02000.0%0.00%
Q4 2014$02000.00%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q4 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,200,000$858,0000.10%
SABBY MANAGEMENT, LLC 1,856,019$724,0000.04%
HOME FEDERAL BANK OF TENNESSEE 100,000$39,0000.03%
Cutter & CO Brokerage, Inc. 94,500$37,0000.02%
WADE G W & INC 80,000$31,0000.01%
Marcus Capital, LLC 15,000$6,0000.01%
PRINCETON CAPITAL MANAGEMENT LLC 10,000$4,0000.01%
B. Riley Wealth Advisors, Inc. 28,000$11,0000.00%
Estate Counselors, LLC 10,000$4,0000.00%
Focused Wealth Management, Inc 2,955$1,0000.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders